Abstract

Lung surfactant reduces surface tension and maintains the stability of alveoli. How surfactant is released from alveolar epithelial type II cells is not fully understood. Vacuolar ATPase (V-ATPase) is the enzyme responsible for pumping H+ into lamellar bodies and is required for the processing of surfactant proteins and the packaging of surfactant lipids. However, its role in lung surfactant secretion is unknown. Proteomic analysis revealed that vacuolar ATPase (V-ATPase) dominated the alveolar type II cell lipid raft proteome. Western blotting confirmed the association of V-ATPase a1 and B1/2 subunits with lipid rafts and their enrichment in lamellar bodies. The dissipation of lamellar body pH gradient by Bafilomycin A1 (Baf A1), an inhibitor of V-ATPase, increased surfactant secretion. Baf A1-stimulated secretion was blocked by the intracellular Ca2+ chelator, BAPTA-AM, the protein kinase C (PKC) inhibitor, staurosporine, and the Ca2+/calmodulin-dependent protein kinase II (CaMKII), KN-62. Baf A1 induced Ca2+ release from isolated lamellar bodies. Thapsigargin reduced the Baf A1-induced secretion, indicating cross-talk between lamellar body and endoplasmic reticulum Ca2+ pools. Stimulation of type II cells with surfactant secretagogues dissipated the pH gradient across lamellar bodies and disassembled the V-ATPase complex, indicating the physiological relevance of the V-ATPase-mediated surfactant secretion. Finally, silencing of V-ATPase a1 and B2 subunits decreased stimulated surfactant secretion, indicating that these subunits were crucial for surfactant secretion. We conclude that V-ATPase regulates surfactant secretion via an increased Ca2+ mobilization from lamellar bodies and endoplasmic reticulum, and the activation of PKC and CaMKII. Our finding revealed a previously unrealized role of V-ATPase in surfactant secretion.

Highlights

  • Lipid rafts are specialized microdomains on the plasma membrane and subcellular membranes

  • Our laboratory has earlier reported that SNAP-23, syntaxin 2, NSF and a-SNAP are critical for lung surfactant secretion [9,10]

  • To determine which pathway(s) is involved in the V-ATPasestimulated surfactant secretion, we examined the effects of protein kinase C (PKC) and calmodulin-dependent protein kinase II (CaMKII) inhibitors on the Bafilomycin A1 (Baf A1)-mediated secretion since [Ca2+]i is involved in the Baf A1-stimulated surfactant secretion

Read more

Summary

Introduction

Lipid rafts are specialized microdomains on the plasma membrane and subcellular membranes. Lipid rafts are implicated in exocytosis [1,2], endocytosis [3], signal transduction [4], membrane trafficking [5], bacterial entry [6], and virus budding [7]. They are associated with a number of metabolic diseases including Alzheimer’s [8]. Knock-down of flotillin-2, a lipid raft marker that is present on the lamellar body and plasma membranes, decreases surfactant secretion [11]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.